Chart calendar Dianthus Therapeutics, Inc.

c1662b1220.KcgljpgUdJNFgECzPhWl0lMFJSZPhfbmFIavxiaac5Y.cI914dFbLd0rrSLFSmznmDVjb2147s6IIbLmhBLWMtxPghT-rHUHxiDYCQ~cc62e5840483410916e4dd188542f6ad

Upcoming events on Dianthus Therapeutics, Inc.

Today 10:55 am Cantor Global Healthcare Conference
2024-09-18 10:30 am Stifel Immunology and Inflammation Virtual Summit
2024-11-06 Q3 2024 Earnings Release (Projected)
2025-03-19 Q4 2024 Earnings Release (Projected)
2025-05-07 Q1 2025 Earnings Release (Projected)
2025-08-06 Q2 2025 Earnings Release (Projected)

Past events on Dianthus Therapeutics, Inc.

2024-09-11 02:00 pm Baird Global Healthcare Conference
2024-08-08 04:01 pm Q2 2024 Earnings Release
2024-06-06 01:30 pm Jefferies Global Healthcare Conference
2024-05-23 09:00 am Annual General Meeting
2024-05-14 07:20 pm BofA Securities Health Care Conference
2024-05-09 04:01 pm Q1 2024 Earnings Release
2024-04-14 American Academy of Neurology Meeting
2024-03-21 04:01 pm Q4 2023 Earnings Release
2024-03-04 02:50 pm TD Cowen Health Care Conference
2024-02-07 10:30 am Guggenheim Healthcare Talks Biotechnology Conference
2024-01-11 01:30 pm JPMorgan Healthcare Conference
2023-11-27 Evercore ISI HealthCONx Conference
2023-11-13 Jefferies London Healthcare Conference
2023-11-09 04:05 pm Q3 2023 Earnings Release
2023-11-05 Guggenheim Securities Inflammation & Immunology Conference

Annual results

Fiscal PeriodDecember 2022 2023 2024 2025 2026
Net sales
Million USD
Released
Forecast
Spread
0,00


2,83
2,52
12.13%

3,93


2,68


3,80

EBITDA
Released
Forecast
Spread
0,00


0,00
0,00
-

0,00


0,00


0,00

EBIT
Million USD
Released
Forecast
Spread
0,00


-48,2
-63,0
23.48%

-90,4


-111


-134

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
0,00


-43,6
-58,1
25.1%

-74,7


-98,3


-125

Net income
Million USD
Released
Forecast
Spread
-28,5


-43,6
-58,1
25.07%

-74,7


-98,3


-125

EPS
USD
Released
Forecast
Spread
-7,10


-8,45
-5,62
-50.46%

-2,32


-2,81


-3,35

Announcement Date01/08/2321/03/24-

Quarterly results

Fiscal PeriodJuni 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million USD
Released
Forecast
Spread
0,92
0,25
269.6%
0,46
0,44
4.15%
0,87
0,37
135.33%
1,86
0,32
477.23%

0,52


0,52


0,47


0,47


0,47


0,47

EBIT
Million USD
Released
Forecast
Spread
-15,8
-9,20
-71.38%
-13,0
-15,8
18.11%
-17,8
-14,7
-21.58%
-22,2
-18,9
-17.2%

-24,5


-26,0


-25,5


-26,6


-27,7


-28,8

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
-14,8
-8,31
-77.71%
-10,6
-15,2
30.38%
-13,7
-13,5
-1.81%
-17,6
-15,0
-17.47%

-20,0


-22,4


-21,1


-23,0


-24,1


-25,5

Net income
Million USD
Released
Forecast
Spread
-14,8
-8,31
-77.71%
-10,6
-15,2
30.38%
-13,7
-13,5
-1.81%
-17,6
-15,0
-17.47%

-20,0


-22,4


-21,1


-23,0


-24,1


-25,5

EPS
USD
Released
Forecast
Spread
-3,78
-0,56
-575%

-1,02

-0,54
-0,44
-23.29%
-0,51
-0,55
6.52%

-0,61


-0,68


-0,70


-0,76


-0,78


-0,76

Announcement Date09/11/2321/03/2409/05/2408/08/24------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. DNTH Stock
  4. Calendar Dianthus Therapeutics, Inc.
-40% Exceptional Extension: Our subscriptions help you unlock hidden opportunities. Exceptional extension!
BENEFIT NOW